Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Armine K Smith

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Urology|September 13, 2025
Editorial Comment on "Hematuria Cancer Risk Score in Combination With Oncuria-Detect for Patients Undergoing Evaluation for Hematuria"Armine K Smith
European Urology Focus|December 8, 2024
Microbiome-based Therapeutics: Cutting-edge Innovation or Perpetual Promise?David J McConkey, Jennifer J Barb, Armine K Smith, et al.
European Urology|December 4, 2025
The Bladder Tumor Microenvironment Is a Dynamic Ecosystem: How Microbes, Immunity, and Cancer ConvergeDavid J McConkey, Jennifer J Barb, Armine K Smith, et al.
Neoplasia (New York, N.Y.)|May 11, 2010
Comparison of tumor and microenvironment secretomes in plasma and in platelets during prostate cancer growth in a xenograft modelBethany A Kerr, Ranko Miocinovic, Armine K Smith, et al.
The Journal of Urology|October 23, 2009
Optimizing orthotopic bladder tumor implantation in a syngeneic mouse modelEddie S Y Chan, Amit R Patel, Armine K Smith, et al.
BMJ Open|June 10, 2024
ERAS for Ambulatory TURBT: Enhancing Bladder Cancer Care (EMBRACE) randomised controlled trial protocolMichael E Rezaee, Katherine M Mahon, Bruce J Trock, et al.
Cancer|June 22, 2010
Chronic kidney disease after nephroureterectomy for upper tract urothelial carcinoma and implications for the administration of perioperative chemotherapyBrian R Lane, Armine K Smith, Benjamin T Larson, et al.
Cancers|January 28, 2026
Impact of Computational Histology AI Biomarkers on Clinical Management Decisions in Non-Muscle Invasive Bladder Cancer: A Multi-Center Real-World StudyVignesh T Packiam, Saum Ghodoussipour, Badrinath R Konety, et al.
Urology|May 10, 2011
Inadequacy of biopsy for diagnosis of upper tract urothelial carcinoma: implications for conservative managementArmine K Smith, Andrew J Stephenson, Brian R Lane, et al.
Urologic Oncology|January 23, 2025
Metformin intake and risk of metabolic acidosis after radical cystectomy with urinary diversion: A comparative study using data from the TriNetX research networkMaximilian Pallauf, Stephan Brönimann, Michael E Rezaee, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Urology|September 13, 2025
Editorial Comment on "Hematuria Cancer Risk Score in Combination With Oncuria-Detect for Patients Undergoing Evaluation for Hematuria"Armine K Smith
European Urology Focus|December 8, 2024
Microbiome-based Therapeutics: Cutting-edge Innovation or Perpetual Promise?David J McConkey, Jennifer J Barb, Armine K Smith, et al.
European Urology|December 4, 2025
The Bladder Tumor Microenvironment Is a Dynamic Ecosystem: How Microbes, Immunity, and Cancer ConvergeDavid J McConkey, Jennifer J Barb, Armine K Smith, et al.
Neoplasia (New York, N.Y.)|May 11, 2010
Comparison of tumor and microenvironment secretomes in plasma and in platelets during prostate cancer growth in a xenograft modelBethany A Kerr, Ranko Miocinovic, Armine K Smith, et al.
The Journal of Urology|October 23, 2009
Optimizing orthotopic bladder tumor implantation in a syngeneic mouse modelEddie S Y Chan, Amit R Patel, Armine K Smith, et al.
BMJ Open|June 10, 2024
ERAS for Ambulatory TURBT: Enhancing Bladder Cancer Care (EMBRACE) randomised controlled trial protocolMichael E Rezaee, Katherine M Mahon, Bruce J Trock, et al.
Cancer|June 22, 2010
Chronic kidney disease after nephroureterectomy for upper tract urothelial carcinoma and implications for the administration of perioperative chemotherapyBrian R Lane, Armine K Smith, Benjamin T Larson, et al.
Cancers|January 28, 2026
Impact of Computational Histology AI Biomarkers on Clinical Management Decisions in Non-Muscle Invasive Bladder Cancer: A Multi-Center Real-World StudyVignesh T Packiam, Saum Ghodoussipour, Badrinath R Konety, et al.
Urology|May 10, 2011
Inadequacy of biopsy for diagnosis of upper tract urothelial carcinoma: implications for conservative managementArmine K Smith, Andrew J Stephenson, Brian R Lane, et al.
Urologic Oncology|January 23, 2025
Metformin intake and risk of metabolic acidosis after radical cystectomy with urinary diversion: A comparative study using data from the TriNetX research networkMaximilian Pallauf, Stephan Brönimann, Michael E Rezaee, et al.
Pageof 2